Denosumab-induced bone changes in a child: a case report.

Caroline Rutten Claudia Martinez-Rios Alan Daneman

Published in: Pediatric radiology (2024)

We present the case of a 9-year-old girl who developed striking bone changes following two years of denosumab therapy for giant cell lesions of the jaw.

Keyphrases

giant cell
bone mineral density
postmenopausal women
body composition
soft tissue
high glucose
bone regeneration
mental health
diabetic rats
drug induced
oxidative stress
endothelial cells